ITMCTR1900002557尚未招募未知
A multicenter randomized, double-blind, controlled trial for efficacy of YueJu Pills in the treatment of antidepressant
Zhongda Hospital affiliated to Southeast University0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 65(—)
- 性别
- All
入选标准
- •1. Meet the diagnostic criteria for DSM-V or ICD-10 depression;
- •2. Aged 18-65 years old;
- •3. Patients with mild to moderate depression, Hamilton Depression Scale (24 items) score 35 points = HAMD-24 = 20 points;
- •4. In the past 1 week, there have been no Chinese medicines used to treat depression (including Chinese medicine and decoction), western medicine (fluoxetine, escitalopram, venlafaxine, etc.), or in the short term (3-5) Those who have taken the above drugs within days) have been discontinued for more than 7 days;
- •5. Willing to accept 42 days of treatment, the subject informed consent, and signed informed consent;
- •6. Both are right-handed and emmetropia.
排除标准
- •1. Patients with suicidal depression, the score of the third item of Hamilton Depression Scale = 2 points;
- •2. People who are suffering from mental illness other than depression, as well as those caused by external environmental disturbances or traumatic brain injury;
- •3. Pregnant or lactating women;
- •4. A history of drug allergy;
- •5. Under 18 years of age or 65 years of age or older;
- •6. Combined with severe primary diseases such as cardiovascular, pulmonary, liver and kidney and hematopoietic system, and patients with severe brain organic diseases and mental illness;
- •7. Alcohol and/or psychoactive substances, drug abusers and dependents (including sleeping pills);
- •8. Does not meet the inclusion criteria, does not use the drug according to the regulations, can not judge the efficacy or incomplete data, affecting the efficacy and safety judgment;
- •9. Unable to understand scale content due to lack of consciousness, language barriers, and intellectual and cultural level;
- •10. Left hand;
- •11. During the elution period (within 7 days), the patient's depressive symptoms return to a healthy state, that is, the Hamilton Depression Scale score = 20 points after the end of the elution period;
- •12. Those who have been depression for more than 2 years.
研究者
相似试验
尚未招募
1 期
A multicenter, double-blind, randomized controlled trial on the effect of DLTM Formula on the progression of coronary calcification in patients with stable coronary heart diseaseITMCTR2024000060Xiyuan Hospital, China Academy of Chinese Medical Sciences
招募中
2 期
A multicenter randomized, controlled, double-blinded trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitisG04Encephalitis, myelitis and encephalomyelitisautoimmune encephalitisDRKS00017497Friedrich-Schiller-Universität Jena50
已完成
不适用
A randomized, double-blind, controlled multicenter trial for availability of carbon dioxide insufflation during ERCP for reduction of postprocedure paipancreaticobiliary diseaseJPRN-UMIN000003062Department of Gastroenterology, Hokkaido University Graduate School of Medicine100
进行中(未招募)
1 期
A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune EncephalitisMedDRA version: 20.0Level: PTClassification code: 10072378Term: Encephalitis autoimmune Class: 100000004852autoimmune encephalitisCTIS2024-514494-21-00Friedrich-Schiller-Universitaet Jena50
尚未招募
1 期
A multicenter, randomized controlled, double-blind and double simulated clinical evaluation of gandouling tablet in the treatment of Wilson's diseaseWilson's diaseaseITMCTR2100005333The First Affiliated Hospital of Anhui University of traditional Chinese Medicine
